Skip to content
healthcare.dev

Ganirelix Acetate

NDC 65219-028, Ganirelix Acetate, injection, from Fresenius Kabi USA, LLC.

Product NDC
65219-028
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215658
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-028 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GANIRELIX ACETATE250 ug/.5mL

Pharmacologic classes

Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]

Package NDCNDC-11Package
65219-028-05652190028051 SYRINGE, GLASS in 1 CARTON (65219-028-05) / 1 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c23ca7b2-7350-4f07-8adf-046bffb47842
  • NADAC price for package 65219002805

    GET /v1/drugs/nadac/65219002805

Use it

Look up 65219-028 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-028 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-028. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.